Novartis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.

About NVS

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. 

CEO
Vasant Narasimhan
CEOVasant Narasimhan
Employees
75,267
Employees75,267
Headquarters
Basel, Basel-Stadt (Basle Town)
HeadquartersBasel, Basel-Stadt (Basle Town)
Founded
1996
Founded1996
Employees
75,267
Employees75,267

NVS Key Statistics

Market cap
298.40B
Market cap298.40B
Price-Earnings ratio
20.68
Price-Earnings ratio20.68
Dividend yield
2.11%
Dividend yield2.11%
Average volume
1.46M
Average volume1.46M
High today
$146.67
High today$146.67
Low today
$145.48
Low today$145.48
Open price
$146.44
Open price$146.44
Volume
989.80K
Volume989.80K
52 Week high
$170.46
52 Week high$170.46
52 Week low
$104.93
52 Week low$104.93

NVS News

TipRanks 3d
Novartis breaks ground on radioligand therapy manufacturing site in Texas

Novartis (NVS) broke ground on its new 46,000 sq. ft radioligand therapy manufacturing site in Denton, Texas, the latest milestone in its broader $23B investmen...

Analyst ratings

50%

of 28 ratings
Buy
35.7%
Hold
50%
Sell
14.3%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.